Delivery Order SPE2DB20D9331-SPE2DB25FL1V3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,556.52, is for the delivery of a pharmaceutical product, specifically VisionBlue 0.06% Syringe 0.5ML. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical pharmaceutical prime vendor contract to provide 0.06% VisionBlue syringes in 0.5mL quantities. The $1,556.54 order is for delivery to a facility located in Park Ridge, Illinois, with a completion date of January 5, 2024. As a woman-owned small business, DMS Pharmaceutical Group supplies pharmaceuticals and medical products in support of Defense Logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,136.10 by the Defense Logistics Agency (DLA) on August 25, 2025. The contract calls for delivery of TissueBlue 0.025% Syringe 0.5ML, a pharmaceutical product to be delivered to Park Ridge, Illinois, with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois, is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML medical supplies. The contract, valued at $1,634.04, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has no set-aside designation and is part of DMS Pharmaceutical Group's broader prime vendor contract SPE2DB, valued up to...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $16,632.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on July 23, 2025, represents one of numerous task orders issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500 million through November 2026....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA to...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1V3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,227.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VisionBlue 0.06% syringes in 0.5ML units. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge facility and will deliver the medical consumables to support Department of Defense healthcare requirements. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The IDC establishes the company as a primary supplier for an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. As a consistent partner with the DLA, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in federal pharmaceutical procurement and maintain its critical role in the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/25/25 |